Utrophin requires α-Syntrophin to maintain neuromuscular junction integrity in mdx mice
Human Molecular Genetics · 26.06.2026 · 35 (13)
DOI: 10.1093/hmg/ddag060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 02.07.2026. Verfasst von Alissa Wierenga und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular, Cellular, and Developmental Biology, 1105 N. University Avenue, Ann Arbor, Michigan, 48109, USA. Hauptthemen laut MEDLINE: Neuromuscular Junction, Utrophin, Dystrophin-Associated Proteins, Calcium-Binding Proteins. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIH HHS, University of Michigan.
Abstract (Originalsprache)
Dystrophin links the actin cytoskeleton to the extracellular matrix through the dystrophin–glycoprotein complex (DGC), providing structural stability to muscle fibers. In mdx mice, which lack dystrophin, neuromuscular junctions (NMJs) remain largely structurally and functionally intact despite extensive muscle pathology. Here, using single- and double-mutant mice deficient in dystrophin and α-syntrophin (α-syn), we investigated how utrophin upregulation contributes to NMJ maintenance in dystrophic muscle. During early postnatal development, when dystrophic muscles are transiently resistant to degeneration, the DGC proteins α-dystrobrevin, α-syn, and β-dystroglycan are broadly distributed along both synaptic and extra-synaptic regions of the sarcolemma, although their overall levels are reduced compared with wild-type (WT) muscle. In contrast, in WT mice, utrophin is restricted to NMJs, whereas in dystrophic muscles from both mutants, it is distributed along both synaptic and extra-synaptic regions of the sarcolemma, particularly within the innervated zone of muscle fibers. As muscles mature and degeneration begins, these DGC components become highly restricted to NMJs while being markedly reduced or absent from the extra-synaptic sarcolemma in many muscle cells. Although utrophin remains highly enriched at synaptic sites in mdx:α-syn−/− muscles, their NMJs display severe structural abnormalities compared with those of mdx mice. These include a dramatic reduction in synaptic fold depth and density, a decrease in presynaptic vesicle density, retraction of nerve terminals, and axonal thinning. These findings demonstrate that utrophin localization at the NMJ is not sufficient to preserve synaptic integrity and that functional interactions between utrophin and α-syn are required to maintain the NMJ in dystrophic muscle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular, Cellular, and Developmental Biology, 1105 N. University Avenue, Ann Arbor, Michigan, 48109, USA.
- Michigan Neuroscience Institute, University of Michigan, 2800 Plymouth Road, NCRC B25-1793, Ann Arbor, MI 48109, United States.
ORCID-Profile: Mohammed Akaaboune
Förderung
- NINDS NIH HHS
- NIH HHS
- University of Michigan
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
Zitieren
APA
Wierenga, A., Mendoza, M., Malik, S. O., Agrawal, A., Reda, A., Maag, A., Abou-Rjaily, A., Gao, C., & Akaaboune, M. (2026). Utrophin requires α-Syntrophin to maintain neuromuscular junction integrity in mdx mice. Human Molecular Genetics, 35(13). https://doi.org/10.1093/hmg/ddag060
Vancouver
Wierenga A, Mendoza M, Malik SO, Agrawal A, Reda A, Maag A, et al. Utrophin requires α-Syntrophin to maintain neuromuscular junction integrity in mdx mice. Human Molecular Genetics. 2026;35(13). doi:10.1093/hmg/ddag060
BibTeX
@article{Wierenga2026,
author = {Wierenga, Alissa and Mendoza, Michelle and Malik, Saad O and Agrawal, Akash and Reda, Aya and Maag, Abigail and Abou-Rjaily, Ameen and Gao, Chenlang and Akaaboune, Mohammed},
title = {Utrophin requires α-Syntrophin to maintain neuromuscular junction integrity in mdx mice},
journal = {Human Molecular Genetics},
year = {2026},
volume = {35},
number = {13},
doi = {10.1093/hmg/ddag060}
}
EUVIMED